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Localization of a Gene for Migraine without Aura to Chromosome 4q21
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Migraine is a common form of headache and has a significant genetic component. Here, we report linkage results
from a study in Iceland of migraine without aura (MO). The study group comprised patients with migraine recruited
by neurologists and from the registry of the Icelandic Migraine Society, as well as through the use of a questionnaire
sent to a random sample of 20,000 Icelanders. Migraine diagnoses were made and confirmed using diagnostic criteria
established by the International Headache Society. A genomewide scan with multipoint allele-sharing methods was
performed on 289 patients suffering from MO. Linkage was observed to a locus on chromosome 4q21 (LODp
; ). The locus reported here overlaps a locus (MGR1) reported elsewhere for patients with migraine2.05 Pp .001
with aura (MA) in the Finnish population. This replication of the MGR1 locus in families with MO indicates that
the gene we have mapped may contribute to both MA and MO. Further analysis indicates that the linkage evidence
improves for affected females and, especially, with a slightly relaxed definition of MO ( ;LODp 4.08 Pp 7.2#
).5610
Introduction
Migraine (MIM 157300) is a common headache disorder
that usually begins in early adulthood and affects ∼18%
of females and ∼6% of males every year (Stewart et al.
1992). It is characterized by recurrent, unilateral, pulsat-
ing headaches of moderate-to-severe intensity, aggravated
by physical activity; the headaches are of 4- to 72-h du-
ration. Other manifestations of the disease include nausea,
vomiting, photophobia, and phonophobia. The diagnos-
tic criteria most commonly used are the standardized
guidelines of the International Headache Society (IHS)
(Headache Classification Committee of the International
Headache Society [HCCIHS] 1988).
Migraine without aura (MO) or “common migraine,”
affects ∼58% of migraineurs (Russell et al. 1995b). Mi-
graine with aura (MA) or “classic migraine” is the form
of migraine with headache attacks preceded by neuro-
logic manifestations, called “aura,” and affects ∼28%
of migraineurs (Russell et al. 1995b). Both subtypes of
migraine can occur within the same family (Nyholt et
al. 1998a, 1998b; Carlsson et al. 2002; Lea et al. 2002)
or in the same individual (Rasmussen and Olesen 1992;
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Launer et al. 1999; Kallela et al. 2001b). A recent ques-
tionnaire-based clinical study in Finland indicates that
the migraine subtype breakdown for families with four
or more migraineurs is as follows: 23% have only MO,
41% experience both MA and MO episodes, 11% have
only MA, 20% have unclassified aura, and 3% have
migraine aura without headache (Kallela et al. 2001b).
In a population-based twin registry, the number of dis-
cordant twins with MA or MO did not indicate that
these phenotypes co-occur more frequently than by
chance, which suggests that they are distinct entities,
inherited independently (Russell et al. 2002). Some epi-
demiology studies have further emphasized differences
between MA and MO, with the former commonly hav-
ing unilateral headaches and photophobia and the latter
having headaches of greater duration and more nausea
(Kallela et al. 1999).
Twin studies of migraine with and without aura in-
dicate a genetic component of ∼40%–65% (Honkasalo
et al. 1995; Larsson et al. 1995; Gervil et al. 1999a,
1999b; Ulrich et al. 1999a, 1999b). This is further sup-
ported by studies of familial clustering of migraine (Mo-
chi et al. 1993; Russell et al. 1995a; Stewart et al. 1997).
The genetic component of the two major subtypes of
migraine, MO and MA, was evaluated in a Danish twin
study (Ulrich and Gervil 2000). The probandwise con-
cordance rates were significantly higher for MZ twins
than for DZ twins for both MO and MA, indicating a
genetic component for susceptibility to migraine. Their
data were also consistent with several studies indicating
greater relative risks for MA than for MO (Russell and
Olesen 1995; Stewart et al. 1997). The results of a Swed-
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ish twin study have suggested that the genetic compo-
nent in migraine is more prominent for females than for
males (Larsson et al. 1995).
A rare Mendelian subtype of MA is called “familial
hemiplegic migraine” (FHM), which is characterized by
unilateral motor weakness during the aura and by hemi-
cranial headaches (HCCIHS 1988). Mutations at the
FHM1 locus (MIM 141500), in the calcium channel
gene CACNA1A (MIM 601011) on 19p13.1, have been
shown to cause 30%–50% of the FHM cases that have
been studied (Joutel et al. 1993; Ophoff et al. 1996; Duc-
ros et al. 2001). Mutations have also been found in this
gene that cause other phenotypes, such as episodic ataxia
type 2 (EA2 [MIM 108500]) (Ophoff et al. 1996) and
spinocerebellar ataxia type 6 (SCA6 [MIM 183086])
(Zhuchenko et al. 1997). Another FHM locus (FHM2
[MIM 602481]) has been mapped to chromosome 1q21-
q23 (Ducros et al. 1997) and mutations identified in a
gene encoding a subunit of a sodium/potassium pump
(ATP1A2 [MIM 182340]) (De Fusco et al. 2003). Finally,
an FHM3 locus (MIM 607516) has been identified on
chromosome 1q31 (Gardner et al. 1997), which may be
the same as the typical migraine locus MGR6 (Lea et al.
2002).
Linkage scans have been made in attempts to map
migraine genes. Linkage scans with typical migraine (MO
or MA) as the phenotype have reported loci on chromo-
some 1q31 (MGR6 [MIM 607516]) (Lea et al. 2002),
6p21.1-p12.2 (MGR3 [MIM 607498]) (Carlsson et al.
2002), and Xq (MGR2 [MIM 300125]) (Nyholt et al.
1998a, 2000). Linkage studies show that MA maps to
4q24 (MGR1 [MIM 157300]) (Wessman et al. 2002)
and 19p13 (MGR5 [MIM 607508]) (Jones et al. 2001),
although typical migraine has also been mapped to the
19p13 locus (Nyholt et al. 1998b; Terwindt et al. 2001).
MO has been mapped to 14q21.2-q22.3 (MGR4 [MIM
607501]) (Soragna et al. 2003). Follow-up association
analysis has been reported only for the locus on
chromosome 19p13, with support for a role for the
insulin receptor gene (INSR [MIM 147670]) (McCar-
thy et al. 2001).
We describe here the results of a genomewide scan for
MO genes in Icelandic families and the mapping of a
major gene to a locus on chromosome 4q21. The map-
ping of MO to the same locus, MGR1, as recently re-
ported for MA, indicates that the same gene may have
a role in both forms of migraine.
Materials and Methods
Patient Material
deCODE Genetics is conducting a large study of mi-
graine in Iceland. Individuals suffering from headache
have been recruited from three sources: (1) a list of pa-
tients provided by two neurologists (401 potential par-
ticipants), (2) responses to an advertisement in the news-
letter of the Icelandic Migraine Society (137 participants),
and (3) responses to a brief screening questionnaire
mailed to a random sample of 20,000 Icelanders, aged
18–50 years and living in the Reykjavik area (including
2,481 respondents who report recurrent headache at-
tacks). From these sources, 2,611 patients with likely
migraine and 1,865 of their close relatives have been
recruited for a genetic study. All recruits were asked to
answer a comprehensive migraine questionnaire (de-
CODE Genetics) before giving blood for the study. The
questionnaire was patterned after the IHS criteria
(HCCIHS 1988). Diagnoses of migraine through a ques-
tionnaire, as done in this study, have been shown to be
highly effective (Kallela et al. 2001a). We have geno-
typed 1,943 patients with headache and 1,510 unaf-
fected relatives, using 1,000 microsatellite markers. Of
the genotyped headache-afflicted patients, 596 meet the
IHS criteria for MO and did not report any aura (138
males and 458 females). There were an additional 702
patients, possibly having MO and reporting some aura
symptoms, who were not included in this analysis, ex-
cept as relatives with unknown affection status. Using
our unique Icelandic genealogy database and clustering
software (Gulcher and Stefa´nsson 1998; Gulcher et al.
2000), we identified 103 families with 289 MO-afflicted
patients who have a relative with MO at or within 5
meioses (i.e., 5 meioses separate first cousins, once re-
moved). This is our primary linkage cohort for the re-
sults presented in this study. This left 307 patients who
were unrelated to other patients with MO within a dis-
tance of 5 meioses; thus, they were not included in the
linkage analyses of the families with MO. Subsequently,
in our investigation of the contribution of phenotypes
to an identified locus, we attempted to increase the num-
ber of patients and families that have no reported aura
by slightly relaxing the IHS criteria for MO, by dropping
either pain criteria C or D but not both (appendix A).
This increased the linkage cohort to 117 families with
351 affected patients. Thus, the two phenotype models
are MO and a less strict version of MO, MO2. We also
considered subsets of these models that consisted of only
male affected members or only female affected members.
The family sets, including the number of relative pairs at
various meiotic distances, are described in table 1. This
study was approved by the National Bioethics Committee
and the Data Protection Commission of Iceland. Informed
consent was obtained from all participants.
Microsatellite Markers and Genotyping
Genotypes were obtained for a marker set developed
at deCODE Genetics that contains markers from the ABI
Linkage marker (v.2) screening and intercalating sets and
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Table 1
Summary of Linkage Families with Count of Affected Relative Pairs
at Various Meiotic Distances
PHENOTYPE
NO. OF
FAMILIES
NO. OF
THOSE
AFFECTED
NO. OF
THOSE
UNAFFECTED
MEIOTIC
DISTANCE
2 3 4
MO:
All patients 103 289 518 67 36 150
Females only 64 167 356 36 20 79
Males only 14 31 70 6 3 8
MO2:
All patients 117 351 553 90 48 186
Females only 77 203 406 46 25 98
Males only 18 39 85 10 4 8
NOTE.—The family counts include only genotyped persons.
500 custom-made markers. The set has 1,000 fluores-
cently labeled primers, with an average spacing of 3.6
cM. The set has been extensively tested for multiplex
PCR results. PCR reactions were set up by Zymark Sci-
Clone (ALH-500) robots, and PCR amplifications were
made on MJ Research machines (PTC-25). The reaction
volume was 5 ml for each PCR reaction, and 20 ng of
genomic DNA was amplified in the presence of 2 pmol
of each primer, 0.25 U AmpliTaq Gold, 0.2 mM dNTPs,
and 2.5 mM MgCl2 (buffer was supplied by Applera).
Cycling conditions were: 95C for 10 min, followed by
37 cycles of 94C for 15 s, annealing for 30 s at 55C,
and 1-min extension at 72C. The PCR products were
supplemented with the internal size standard, and the
pools were separated and detected on 3700 Sequencers
using Genescan (v3.0) peak calling software (Applera).
The genotypes, for a total of 866 markers from the ge-
nomewide set, were used for the linkage analysis, re-
sulting in an average intermarker distance of 4.2 cM.
Alleles were automatically called using DAC, an allele-
calling program developed at deCODE Genetics (Fjalldal
et al. 2001), and the program DecodeGT was used to
fractionate called genotypes, according to quality, and
to edit, when necessary (Pa´lsson et al. 1999).
Statistical Methods for Linkage Analysis
To evaluate linkage, we used multipoint, affected-only
allele-sharing methods. The program Allegro (Gudbjarts-
son et al. 2000) was used for calculating nonparametric
linkage and LOD scores, as well as for producing infor-
mation measures on identity-by-descent (IBD) sharing.
We employed the Spairs scoring function (Whittemore
and Halpern 1994; Kruglyak et al. 1996) and the expo-
nential allele-sharing model (Kong and Cox 1997) to gen-
erate the relevant 1-df test statistic. Family scores were
combined to obtain an overall score, by use of a weight-
ing scheme that is halfway on the logarithm scale be-
tween weighting the families equally (Kruglyak et al.
1996) and by weighting the affected pairs equally; with
the resulting weight equal to the geometric mean of the
two weights. This scheme gives weights similar to those
proposed by Weeks and Lange (1988) as an extension of
the scheme Hodge designed for sibships (Hodge 1984).
To increase our confidence in the evidence for linkage
to a particular region, additional microsatellite markers
were genotyped to increase the information on IBD shar-
ing to85% in that region. For the families in this study,
to achieve this level of information required an average
spacing of markers of ∼1 every 1.5 cM. The marker
order and positions used in linkage analysis are from
our high-resolution genetic map (Kong et al. 2002). All
reported locations are in Kosambi centimorgans.
Results
A genomewide scan was made on 103 families containing
289 genotyped patients with MO and 518 of their ge-
notyped relatives (fig. 1). Five locations had a LOD score
1.5. They are on chromosomes 4p ( atLODp 2.05
D4S394), 4q ( at D4S2361), 18pLODp 1.96
( at D18S453), 18q ( atLODp 1.57 LODp 1.50
D18S877), and 20q ( at D20S96).LODp 1.60
Given that the prevalence of MO in women is three
times that in men, we decided to investigate families re-
stricted to either male patients or female patients. For
males with MO, the LOD scores on chromosomes 4 and
18 dropped to !0.3, whereas the peak on chromosome
20 dropped to !1.0. No LOD score 11.5 was observed.
For females with MO, however, whereas the 4p, 18p,
18q, and 20q peaks dropped to !1.5, the LOD score at
chromosome 4q rose to 2.68 at D4S2361. Figure 2 shows
a comparison of linkage scans on chromosome 4 in males
and females with MO. A region on chromosome 21q
also achieved a LOD score 11.5 for females with MO
( between D21S1896 and D21S1442).LODp 1.74
The 4q peak is interesting, since it overlaps with the
MGR1 locus that was reported by a Finnish group as
being linked to MA (Wessman et al. 2002). We decided
to genotype 15 additional markers at this locus to in-
crease the information on IBD sharing of alleles by af-
fected relatives and to determine if that would support
genetic sharing in the region. After this higher-resolution
mapping, the MO phenotype gave a LOD score of 2.05
( ) at D4S1534 (93.19 cM), thus confirming thePp .001
MGR1 locus. The run for males with MO continued to
show no evidence for linkage to this region, and the run
for females with MO produced a slightly lower LOD
score than for the framework mapping ( atLODp 2.33
D4S1534). A summary of the fine-mapping results is dis-
played in table 2.
We then expanded our study cohort by including pa-
tients who scored positive for all MO diagnostic criteria
except either criteria C or D but not both (appendix A).
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Table 2
Summary of Fine-Mapping Results
at the Chromosome 4q21 Locus
Phenotype Peak Marker
Position
(cM) LOD
MO:
All patients D4S1534 93.19 2.05
Females only D4S1534 93.19 2.33
Males onlya … … …
MO2:
All patients D4S1534 93.19 2.87
Females only D4S2409 94.23 4.08
Males only D4S2361 92.30 .79
a In the results for only males with MO, the LOD
score is !.10 throughout the region.
Figure 2 Multipoint allele-sharing LOD scores for chromosome 4 of females with MO (solid line) and males with MO (dashed line).
The multipoint allele-sharing LOD score is shown on the vertical axis, and the distance (in Kosambi cM) from the chromosomal p terminus
is on the horizontal axis.
For the 117 families containing 351 genotyped patients
who were diagnosed according to this MO2 criterion,
we observed a LOD score of 2.87, again at D4S1534.
The males with MO2 showed some linkage, with a
LOD score of 0.66, but the females with MO2 gave
a very striking result ( ; ;6LODp 4.08 Pp 7.2# 10
D4S2409; 94.23 cM). The region corresponding to a
drop of 1 in LOD is flanked by markers D4S2627 (91.86
cM) and D4S423 (100.16 cM). Figure 3 shows the high-
resolution mapping of chromosome 4 for males and
females with MO2.
Discussion
Our linkage analysis places a gene for MO in Icelandic
families on chromosome 4q21. Our data indicate that
this MO locus overlaps with a known MA locus, MGR1,
that is reported by a Finnish study (Wessman et al. 2002).
This locus for MA, with peak marker D4S1647 (103.77
cM), was identified using a parametric two-point linkage
model, assuming a dominant mode of inheritance. The
Finnish group also reported its best multipoint para-
metric and nonparametric linkage for MA between
markers D4S2409 and D4S2380, slightly centromeric to
marker D4S1647. We map our peak marker for MO,
D4S1534, to within 1.1 cM of D4S2409, which is near
the peak of the reported MGR1 multipoint locus. This
locus is most prominent for female patients with MO,
especially when including headache patients who were
diagnosed with slightly relaxed criteria for MO (drop-
ping IHS criteria class C or D) (appendix A). We note
that D4S2409 is also in the center of our most prominent
peak for females with MO2. Since D4S2409 maps to
the same physical location as cytogenetic band 4q21, we
suggest that 4q21 may be a better localization for the
MGR1 locus than 4q24.
The peak that we observe on chromosome 18q, at
marker D18S877 in our strict MO linkage run (fig. 1),
is also in the Finnish linkage data (Wessman et al.
2002). Their peak has the same top marker. However,
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Figure 3 Multipoint allele-sharing LOD scores for chromosome 4 of females with MO2 (solid line) and males with MO2 (dashed line),
with a higher-resolution map. With an average intermarker distance of 1.5 cM in the linked region, a multipoint LOD score of 4.08
was detected at marker D4S2409 (94.23 cM). The multipoint allele-sharing LOD score is shown on the vertical axis, and the distance (in
Kosambi cM) from the chromosomal p terminus is on the horizontal axis.
this linkage decreases when the MO2 phenotype
model is analyzed.
An MO locus has been mapped to chromosome
14q21.2-q22.3 in a large Italian pedigree that has a
dominant inheritance pattern (Soragna et al. 2003). We
have no evidence for linkage in this region. Also, no
linkage 11 in LOD score is observed for typical migraine
loci on chromosome 1q31 (MGR6) (Lea et al. 2002),
6p21.1-p12.2 (MGR3) (Carlsson et al. 2002), 19p13
(MGR5) (Nyholt et al. 1998b), or Xq (MGR2) (Nyholt
et al. 1998a, 2000).
The MGR1 locus reported elsewhere is based on 50
Finnish families that have three or more first-degree rela-
tives with MA, with a seemingly dominant mode of in-
heritance (Wessman et al. 2002). In contrast, the Icelandic
cohort with MO is defined as “MO patients who do not
report any symptoms that can be interpreted as aura.”
Headache patients who report only one aura episode but
otherwise five or more MO attacks are not included in
our cohort with MO. We are currently evaluating the
Icelandic MA material and intend to report our findings
on it and other phenotype breakdowns as soon as they
become available.
Our data show that the chromosome 4q21 locus is
more significant when only females are analyzed. This
may relate to the stronger genetic effect that has been
reported for females (Larsson et al. 1995). Epidemio-
logic studies (Rasmussen and Olesen 1992; Russell et
al. 1996; Launer et al. 1999) and population-based twin
studies (Kallela et al. 1999; Ulrich et al. 1999a; Svensson
et al. 2002) show that MO is more frequent in females
than males. Our cohort with MO has, similarly, more
affected females than males (458 females and 138
males). The preponderance of females with MO could
relate to a stronger genetic component. We note, however,
that the smaller number of male patients in our study
decreases the power of detecting linkage for males, and
the affect of a gene at this locus on susceptibility in
males may bear further investigation.
On the basis of our data and the Finnish work, the
MGR1 locus may be best characterized as “containing
a gene predisposing to typical migraine that contributes
to both MA and MO,” and the type may be decided by
other gene(s) or environmental factors. However, further
work is necessary to support this conclusion, since no
linkage study has been published on MO in the Finnish
population or on MA in the Icelandic populations.
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Appendix A
Migraine without Aura: International Headache Society
Criteria
Previously used terms: common migraine, hemicrania
simplex.
Diagnostic criteria:
1. At least five attacks fulfilling items B–D.
2. Headache lasting 4–72 hours (untreated or unsuc-
cessfully treated).
3. Headache with at least two of the following char-
acteristics:
A. Unilateral location.
B. Pulsating quality.
C. Moderate or severe intensity (inhibits or prohibits
daily activities).
D. Aggravation by walking stairs or similar routine
physical activity.
4. During headache, at least one of the following:
A. Nausea and/or vomiting.
B. Photophobia and phonophobia.
5. At least one of the following:
A. History and physical and neurologic examinations
do not suggest one of the disorders listed in groups
5–11 (organic disorders).
B. History and/or physical and/or neurologic ex-
aminations suggest such disorder, but it is ruled
out by appropriate investigations.
C. Such disorder is present, but migraine attacks do
not occur for the first time in close temporal re-
lation to the disorder.
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